Cerebral venous thrombosis in adults: the role of imaging evaluation and management (Q30802477)

26 June 2017

1 reference

title

Cerebral venous thrombosis in adults: the role of imaging evaluation and management (English)

1 reference

26 June 2017

1 reference

Seon-Kyu Lee

1

1 reference

26 June 2017

Karel G terBrugge

series ordinal

2

1 reference

26 June 2017

publication date

1 February 2003

1 reference

Neuroimaging clinics of North America

26 June 2017

published in

1 reference

26 June 2017

volume

13

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

139-152

1 reference

Clinical Presentation, Imaging and Treatment of Cerebral Venous Thrombosis (CVT).

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Heparin treatment in sinus venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis: nothing, heparin, or local thrombolysis?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Genetic susceptibility to venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology--evidence for a cytotoxic genesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Changes in the cerebrocortical capillary network following venous sinus occlusion in cats.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Use of local cerebral blood flow monitoring to predict brain damage after disturbance to the venous circulation: cortical vein occlusion model by photochemical dye.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Treatment of dural sinus thrombosis using selective catheterization and urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Endovascular recanalization with balloon angioplasty and stenting of an occluded occipital sinus for treatment of intracranial venous hypertension: technical case report

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Treatment of dural sinus thrombosis with local urokinase infusion. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Acute-Sinus Thrombosis in a Child with Antibodies against Cardiolipins. Report of a Case Treated with Local Fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Clinical-Radiological Correlation in Cerebral Venous Occlusive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Heparin treatment for cerebral venous and sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Isolated straight sinus and deep cerebral venous thrombosis: successful treatment with local infusion of urokinase. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Thrombolysis, clot selectivity, and kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

Treatment of intracranial venous occlusive disease with sigmoid sinus angioplasty and stent placement in a case of infantile multifocal dural arteriovenous shunts

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900095-3

7 January 2021

10.1016/S1052-5149(02)00095-3

Identifiers

DOI

1 reference

26 June 2017

1 reference